US Patent No. 10,660,838 B2
(Tomohiro Hakozaki, John Erich Oblong, Bin Fang Deyer); The Procter & Gamble Company
has patented a method of treating a skin condition without increasing glycation in the collagen of the user. It entails identifying a target portion of skin where treatment is desired and topically applying a cosmetic composition that is comprised of saccharide, a dermatologically acceptable carrier, wherein the composition has a pH of less than 5.0, and wherein the treatment period is sufficient for the composition to improve the skin condition and the composition does not increase glycation relative to a vehicle control in the Advanced Glycation End Product (AGE) Assay.